| cpd00932 | 1067653-18-2 | nuclear localization sequences (NLS) | NXGPKKKRKV | porphine derivative | Anticancer therapy, photosensitizer | amide | Sibrian-et.al (2010)
DOI |
cpd00933 | 1221953-86-1 | nuclear localization sequences (NLS) | GPKKKRKV | porphine derivative | Anticancer therapy, photosensitizer | amide | Sibrian-et.al (2010)
DOI | cpd00934 | 1257268-41-9 | Glu-AQ | RKGRS | 9-Acridinecarboxylic acid | Synthesis and DNA nuclease activity | amide | Alkhader, Shadad;et.al (2010)
DOI | cpd00935 | 1239604-00-2 | Glu-AQ | RGRKG | 2-Anthraquinonecarboxylic acid | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00936 | 1239603-92-9 | Glu-AQ | RKGRS | 2-Anthraquinonecarboxylic acid | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00937 | 1239603-88-3 | Glu-AQ | RKGRS | 2-Anthraquinonecarboxylic acid | Synthesis and DNA nuclease activity | amide | Alkhader, Shadad;et.al (2010)
DOI | cpd00938 | 1239603-86-1 | Glu-AQ | RGRKG | 2-Anthraquinonecarboxylic acid | Synthesis and DNA nuclease activity | amide | Alkhader, Shadad;et.al (2010)
DOI | cpd00939 | 1239603-85-0 | Glu-AQ | RERKG | 2-Anthraquinonecarboxylic acid | Synthesis and DNA nuclease activity | amide | Alkhader, Shadad;et.al (2010)
DOI | cpd00940 | 1239603-84-9 | Glu-AQ | RKGRS | 2-Anthraquinonecarboxylic acid | Synthesis and DNA nuclease activity | amide | Alkhader, Shadad;et.al (2010)
DOI | cpd00941 | 1239604-09-1 | Glu-AQ | XRSRG | 2-Anthraquinonecarboxylic acid | Synthesis and DNA nuclease activity | amide | Alkhader, Shadad;et.al (2010)
DOI | cpd00942 | 1239603-99-6 | Glu-AQ | RGRKG | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00943 | 1239603-98-5 | Glu-AQ | RGRKG | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00944 | 1239603-97-4 | Glu-AQ | GRGRK | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00945 | 1239603-96-3 | Glu-AQ | RERKG | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00946 | 1239603-95-2 | Glu-AQ | RERKG | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00947 | 1239603-94-1 | Glu-AQ | RERKG | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00948 | 1239603-93-0 | Glu-AQ | GRERK | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00949 | 1239603-91-8 | Glu-AQ | RKGRS | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00950 | 1239603-90-7 | Glu-AQ | RKGRS | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00951 | 1239603-89-4 | Glu-AQ | GRSRK | 2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonamide | Synthesis and DNA nuclease activity | sulfonamide | Alkhader, Shadad;et.al (2010)
DOI | cpd00952 | 1197472-94-8 | dipeptide | AV | N-Norgalanthamine | Alzheimer's disease therapy | amide | Lyubomir T.et.al (2009)
DOI | cpd00953 | 1197472-92-6 | dipeptide | AF | N-Norgalanthamine | Alzheimer's disease therapy | amide | Lyubomir T.et.al (2009)
DOI | cpd00954 | 1197472-68-6 | tripeptide | ALG | N-Norgalanthamine | Alzheimer's disease therapy | amide | Lyubomir T.et.al (2009)
DOI | cpd00955 | 1197472-67-5 | tripeptide | AVG | N-Norgalanthamine | Alzheimer's disease therapy | amide | Lyubomir T.et.al (2009)
DOI | cpd00956 | 1197472-66-4 | tripeptide | AFG | N-Norgalanthamine | Alzheimer's disease therapy | amide | Lyubomir T.et.al (2009)
DOI | cpd00957 | 1197472-64-2 | dipeptide | AG | N-Norgalanthamine | Alzheimer's disease therapy | amide | Lyubomir T.et.al (2009)
DOI | cpd00958 | 1197472-60-8 | dipeptide | XG | N-Norgalanthamine | Alzheimer's disease therapy | amide | Lyubomir T.et.al (2009)
DOI | cpd00959 | 1204521-13-0 | | SFFYLRS | 1,3-Diazido-2,4,5-trifluoro-6-nitrobenzene | Anticancer therapy, leukemia | other | Raghavan Rajagopalan,Âet.al (2009)
DOI | cpd00960 | 1204583-20-9 | octarginin | XRRRRRRRR | (8S,10S)-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione | Anticancer therapy, leukemia and hepatoma | amide | Zsanett MiklÃet.al (2009)
DOI | cpd00961 | 1204583-19-6 | hexarginin | XRRRRRR | (8S,10S)-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-Naphthacenedione | Anticancer therapy, leukemia and hepatoma | amide | Zsanett MiklÃet.al (2009)
DOI |